Stock Price Quote

LINCOLN PHARMACEUTICALS LTD.

NSE : LINCOLNBSE : 531633ISIN CODE : INE405C01035Industry : Pharmaceuticals & DrugsHouse : Private
BSE166.400.15 (+0.09 %)
PREV CLOSE ( ) 166.25
OPEN PRICE ( ) 166.15
BID PRICE (QTY) 166.00 (1)
OFFER PRICE (QTY) 166.10 (64)
VOLUME 3831
TODAY'S LOW / HIGH ( )165.70 169.00
52 WK LOW / HIGH ( )85.5 220
NSE166.450.4 (+0.24 %)
PREV CLOSE( ) 166.05
OPEN PRICE ( ) 165.50
BID PRICE (QTY) 166.35 (91)
OFFER PRICE (QTY) 166.45 (8)
VOLUME 14501
TODAY'S LOW / HIGH( ) 165.30 169.45
52 WK LOW / HIGH ( )85.05 218.8
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 20-01 1995
Management Info
Kishor M Shah - Chairman Mahendra G Patel - Managing Director
Registered Office

Address Lincoln House", Behind Satyam Complex,Science City Road,Sola,
Ahmedabad,
Gujarat-380060

Phone 079-30018000

Email info@lincolnpharma.com

Website www.lincolnpharma.com

Registrars Details
Link Intime India Pvt Ltd.
506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad
Listing : BSE, NSE, Ahmedabad

NEWS

19May Lincoln Pharmaceuticals gets European
Lincoln Pharmaceuticals has received the European Union (EU) GMP certifi..
19May Lincoln Pharmaceuticals soars on getti
Lincoln Pharmaceuticals is currently trading at Rs. 165.00, up by 1.15 p..
27Apr Lincoln Pharmaceuticals gets nod to ma
Lincoln Pharmaceuticals has received approval to manufacture Hydroxychlo..
27Apr Lincoln Pharmaceuticals jumps on getti
Lincoln Pharmaceuticals is currently trading at Rs. 152.70, up by 7.25 p..
22Oct Lincoln Pharmaceuticals receives paten
Lincoln Pharmaceuticals has been awarded a patent for its liquid Diclofe..

Financials

in Millions
QTR Dec 19 ANNUAL 19
Net Profit101.78466.37
Gross Profit 120.48 581.42
Operating Profit 139.2669.05
Net Sales 956.43530.43

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr. Reddys Lab (BSE)
peergroup  3913.00 (2.36%)
M.Cap ( in Cr)64890.52
Alkem Laboratories (BSE)
peergroup  2424.95 (3.83%)
M.Cap ( in Cr)28950.27
Aarti Drugs (BSE)
peergroup  1381.00 (4.23%)
M.Cap ( in Cr)3217.96
Piramal Enterprises (BSE)
peergroup  1471.85 (3.90%)
M.Cap ( in Cr)32786.50
IOL Chem & Pharma (BSE)
peergroup  586.80 (6.44%)
M.Cap ( in Cr)3339.76

Shareholding Pattern

NON-INSTITUTION 67.29%
PROMOTERS 32.36%
FI/BANKS/INSURANCE 0.26%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
No Data Found

About Lincoln Pharmaceuticals Ltd.

Lincoln Pharmaceuticals Ltd. was incorporated in the year 1995. Its today's share price is 166.25. Its current market capitalisation stands at Rs 332.4 Cr. In the latest quarter, company has reported Gross Sales of Rs. 3661.81 Cr and Total Income of Rs.3718.32 Cr. The company's management includes Saurin J Parikh, Meha Patel, Pirabhai Suthar, Ishwarlal Patel, Arvind G Patel, Rajnikant G Patel, Ashish Patel, Munjal M Patel, Hashmukhbhai Patel, Mahendra G Patel, Kishor M Shah.

It is listed on the BSE with a BSE Code of 531633 , NSE with an NSE Symbol of LINCOLN and ISIN of INE405C01035. It's Registered office is at Lincoln House", Behind Satyam Complex,Science City Road,SolaAhmedabad-380060, Gujarat. Their Registrars are ACC Ltd. It's auditors are Chandulal M Shah & Co, DK Chhajer & Co, JT Shah & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)